Log In
Print
BCIQ
Print
Print this Print this
 

AzaSite Plus (ISV-502)

  Manage Alerts
Collapse Summary General Information
Company InSite Vision Inc.
DescriptionCombination of azithromycin antibiotic and dexamethasone corticosteroid in InSite's DuraSite ophthalmic drug delivery system
Molecular Target Ribosomal 50S subunit
Mechanism of ActionRibosomal 50S subunit inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase III
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat blepharitis
Regulatory Designation

U.S. - Special Protocol Assessment (Treat blepharitis)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today